To analyse the results of the stress urinary incontinence (SUI) audit conducted by the British Association of Urological Surgeons (BAUS), and to present UK urologists' contemporary management of SUI.
Patients and Methods
The BAUS audit tool is an online resource, to which all UK urologists performing procedures for SUI are invited to submit data. The data entries for procedures performed during 2014-2016 were collated and analysed.
Results
Over the 3-year period analysed, 2917 procedures were reported by 109 surgeons, with a median of 20 procedures reported per surgeon. A total of 2 366 procedures (81.1%) were recorded as a primary surgery, with 548 procedures (18.8%) performed for recurrent SUI. Within the time period analysed, changes were noted in the frequency of all procedures performed, with a trend towards a reduction in the use of synthetic mid-urethral tapes, and a commensurate increase in the use of urethral bulking agents and autologous fascial slings. A total of 107 (3.9% of patients) peri-operative complications were recorded, with no association identified with patient age, BMI or surgeon volume. Follow-up data were available on 1832 patients (62.8%) at a median of 100 days postoperatively. Reduced pad use was reported in 1311 of patients (84.5%) with follow-up data available and 86.3% reported a pad use of one or less per day. In all, 375 patients (85%) reported being satisfied or very satisfied with the outcome of their procedure at follow-up, although data entry for this domain was poor. De novo overactive bladder (OAB) symptoms were reported by 15.2% of patients (263/ 1727), and this was the most commonly reported postoperative complication. For those reporting pre-existing OAB prior to their SUI surgery, 28.7% (307/1069) of patients reported they got better after their procedure, whilst 61.9% (662/1069) of patients reported no change and 9.4% of patients (100/1 069) got worse.
Introduction
There has been significant controversy associated with the use of synthetic mesh in the repair of pelvic organ prolapse and treatment of stress urinary incontinence (SUI), with a number of successful high-profile lawsuits for adverse outcomes against mesh manufacturers in the USA [1] . In 2014, the Scottish health minister recommended suspending all such mesh use, pending a formal review. This recommendation was reversed following the review and publication of the final Scottish Independent Review in 2017 [2] . The report recommended that women choosing surgery for SUI should be offered all available and suitable options (including mesh and non-mesh procedures).
The Scottish Independent Review was accompanied by reviews from England (The UK Mesh Oversight Group) [3] , Europe (SCENIHR) [4] and Australasia (Royal Australian and New Zealand College of Obstetricians and Gynaecologists) [5] , all of which concluded that synthetic mid-urethral tape (MUT) operations for SUI were a safe and effective treatment option and should continue to be offered to women seeking surgical treatment for their SUI. Australasia subsequently announced a ban on some vaginal mesh surgery, including single-incision mini-slings for SUI [6] . A large (> 13 000) population-based cohort study reviewed all adverse events after first, single, mesh and non-mesh surgical procedures for SUI and pelvic organ prolapse in Scotland between 1997 and 2016 and concluded that women who had MUT procedures for SUI reported a low incidence of immediate complications and equivalent risks of later complications [7] . A recent paper examining adverse events from 92 246 vaginal MUT urinary incontinence procedures (based on NHS Hospital Episode Statistics) found that peri-procedural and 30-day complication rates were 2.4% and 1.7%, respectively, with 5.9% of patients readmitted within 5 years for further mesh intervention or symptoms of complications (there is a lack of detail of what these complications were). In this cohort, 93.9% patients undergoing tension-free vaginal tape (TVT) and 94.4% patients undergoing transobturator tape (TOT) remained free from further surgery or admission for complications after 5 years [8] .
In 2006 (updated in 2013 and 2015), the National Institute for Health and Care Excellence (NICE) issued guidance on the management of urinary incontinence in women [9] . Based on the expert opinion of the committee with minimal evidence, the guidance indicated that surgeons performing SUI surgery in England should undertake an annual workload of at least 20 cases of each primary procedure, and advised that surgeons performing less than five of any procedure do so only with the support of their clinical governance committee. They also recommended that surgeons maintain audit data and submit to a national registry such as the BAUS audit.
Following the 2012 governmental announcement of the plan to publish individual surgeon outcome data [10] , the British Association of Urological Surgeons (BAUS) initiated a number of nationwide audits to capture current UK urological practice and outcomes. The BAUS nephrectomy audit data were published in 2013, followed by percutaneous nephrolithotomy, radical prostatectomy, urethroplasty, female SUI procedures and cystectomy. The present paper focuses on the female SUI procedures audit, which was set up as an independent audit in response to NHS England's request for a Healthcare Quality Improvement Partnership audit for MUTs. It was first published at surgeon-and centre-level in 2015 on the BAUS [11] and NHS Choice websites [12] . All BAUS-registered urologists are invited to take part in these audits, with regular reminders sent to promote data entry and data verification. These audits reflect real-life clinical practice and not tightly defined research protocols. Although there are many advantages such as large datasets and benchmarking, there are difficulties around data entry, bias and comprehensive data collection [13] .
The aim of the present report was to summarize contemporary surgical management of female SUI by UK urological surgeons over a 3-year period. Importantly, we aim to put the above controversies into context by providing an accurate description of current surgical practice and to examine patterns in short-term outcomes and complications, with particular reference to MUT surgeries for SUI and the number of procedures performed.
Patients and Methods

Data Collection
The BAUS audit tool is an online resource, to which all UK urologists performing procedures for SUI are invited to submit data. Surgeon-specific data include the type and number of procedures performed. Patient demographics include age and body mass index (BMI). Pre-operative urodynamic outcomes, discussion at multidisciplinary team meeting, catheter dependence, pad use and previous SUI surgery are also recorded. Outcomes measured at 3 months included peri-operative and postoperative complication rates, postoperative catheter usage, and patient-reported outcome measures at baseline and 3 months (measured using the validated five-level version of the EQ-5D quality-of-life questionnaire [EQ-5D-5L]) [14] and International Consultation on Incontinence Questionnaire short-form on urinary incontinence (ICIQ-UI-SF) [15] . One of the five domains in the EQ-5D-5L measures pain in a non-specific manner and was used to compare postoperative pain levels. A binary question of persistent postoperative pain was also asked and, if positive, the site of pain recorded. Results are collated centrally by BAUS. Results were analysed with reference to Hospital Episodes Statistics (HES) data [16] , an anonymized database containing details of all admissions, Accident and Emergency attendances and outpatient appointments at NHS hospitals in England. The data come from the routine submissions of data from providers to NHS Digital for the purposes of payment for and commissioning of healthcare in England, with regular validation and cleaning of submissions by NHS Digital. SUI surgery can be identified by centre and speciality but not by surgeon. This allowed the capture rate calculation for each year's audit but does not allow determination of individual surgeon capture rate.
Results
Data collection began in 2012; however, a low number of procedures were recorded in 2012 (n = 150) and 2013 (n = 397). This has subsequently increased significantly, with 1041 and 1087 procedures recorded in 2014 and 2015, respectively. In line with the overall decrease in uptake of SUI surgery [16] , 789 procedures were recorded in 2016. Data including follow-up assessment from procedures performed between 2014 and 2016 inclusive have been analysed in this review as the data captured during this period reflect a period where the majority of UK urologists were submitting their results, with a capture rate of 72%, cross-checked with HES data.
Surgeon Caseload
In total over the 3-year period analysed, 2917 procedures were reported, including 250 cases performed in the private sector. Of these, 2366 (81.1%) were recorded as a primary procedure, with 548 procedures (18.8%) performed as a secondary procedure for recurrent SUI. Data were registered by 109 surgeons, with a median (range) of 20 (1-122) procedures performed per surgeon over the 3-year period. Only 11 UK urologists recorded 60 procedures or more in total over the data collection period, which would, on average, equate to 20 procedures or more performed per year. The NICE guideline threshold of 20 or more procedures per year, however, refers to each individual procedure rather than the total number performed. A breakdown of procedures performed can be seen in Table 1 .
Changes were noted in the frequency of all procedures performed within the time period analysed. The use of MUT, including TVT, tension-free vaginal tape-obturator (TVT-O), TOT and mini-tapes significantly fell from 81.4% (847/1 041) of all procedures recorded in 2014 to 65.9% (520/789) in 2016 (P < 0.001). This was matched by a fall in total number of procedures for SUI from 1041 to 789. The use of urethral bulking agents significantly increased from 3.7% (39) to 13.7% (108; P < 0.001), with a significant increase in the rate of autologous fascial sling (AFS) procedures from 8.3% (86) to 12.8% (101; P < 0.001). The numbers of colposuspensions performed did not significantly change, going from 4% (42) in 2014 to 4.9% (39) in 2016 (Fig. 1 of caseload, respectively; P < 0.001). All three cohort groups offered all procedures with the exception of the mini-tape, which was offered by only one surgeon (who was in the high-volume group; Table 2 ).
Patient Demographics
There was significant variability in the demographics of patients undergoing surgery for SUI. The mean (range) patient age was 54 (17-94) years (valid data from 2 900 women, 99.4% of analysed cohort). The majority of patients were overweight, with a mean (range) BMI of 29.7 (15-55.6) kg/m 2 (valid data from 1 687 women, 57.8% of cohort). The majority of patients (74.2%, 1727/2327) had no comorbidities. Of those with a recorded Charlson comorbidity index (CCI) score [17] (n = 2320, 79.5%), which predicts 1-year mortality for a patient who may have a range of comorbid conditions, 1774 (76.5%) had a CCI score of 0, 318 (13.7%) had a CCI score of 1, 146 (6.3%) had a CCI score of 2 and 45 (1.9%) had a CCI score of 3. The remaining 37 patients (1.6%) had a CCI score of between 4 and 9.
Preoperatively, 93.3% (2551/2735) of patients underwent urodynamic assessment. The predominant recorded finding was pure urodynamic stress incontinence (74.2%, 1799/2424), followed by urodynamic mixed urinary incontinence (20.4%, 495/2424) ( Table 3 ). The majority of patients (88%, 2113/ 2402) were using at least two pads a day, with 351 (14.6%) reporting a pad use of more than five pads per day.
When describing the degree of incontinence, the majority of patients (1145/1909, 60%) reported leaking several times per day, with a further 328 (17.2%) reporting leaking all the time (Table 4) . A total of 69.4% of patients (1320/1902) reported leaking a moderate or large amount (Table 4) .
Peri-operative Outcomes
Of 1273 patients (48.1%) who left theatre with a catheter in situ (recorded in 2644, 90.6%). Of 1 196 patients with the time of trial without catheter recorded, 836 (69.9%) had their catheter removed within 24 h. Only 5.5% of patients (63/ 1150) were recorded as starting unplanned clean intermittent self-catheterization. The median postoperative length of stay was 1 day, with just under half of cases (1036/2 325, 44.6%) performed as a day case.
In total, 107 cases (3.9%, n = 2756) were reported to have peri-operative complications, including 36 (1.3%) bladder perforations and six (0.22%) urethral perforations. In six (0.22%) cases the procedure was abandoned, including one case for urethral perforation and one for bladder perforation. The rate of complications was significantly higher (P < 0.001) in those undergoing recurrent SUI surgery (36 complications, 7.1%, n = 509) compared with primary surgery (71 complications, 3.2%, n = 2245) although the absolute number of complications was very low.
There was no association of peri-operative complications with groups stratified by patient age, BMI or surgeon volume. Complications were more likely in those undergoing a colposuspension, AFS or artificial urinary sphincter (AUS; P < 0.001) than for other procedures although, again, the absolute number of complications was very low. The breakdown of complications per procedure can be seen in Table 5 .
Follow-up Data
Follow-up data were available in 1832 patients (62.8% cases), and are summarized in Table 6 De novo overactive bladder (OAB) was reported by 15.2% of patients (263/1727) after their procedure; this was more common in those having surgery for recurrent SUI, and in those having colposuspension, AUS and AFS procedures, the latter being the most commonly used procedure for recurrent SUI; however, there are some discrepancies in the reported rate of de novo OAB, and a risk of over-reporting of newonset OAB, as some patients reporting de novo OAB had reported pre-existing OAB. For those reporting pre-existing OAB prior to their SUI surgery, 28.7% of patients (307/1069) reported they got better after their procedure, whilst 61.9% of patients (662/1069) reported no change and 9.4% of patients (100/1069) got worse.
At follow-up appointment, 7.5% of patients (130/1743) reported a UTI. Of these, 60.3% (76/126) had positive microscopy. All were treated with antibiotic therapy.
The rate of tape extrusion reported in the present series was <1% (14/1717); this number was too small to allow valid statistical analysis in terms of patient or surgeon demographics.
A total of 3.5% of patients (44/1242) reported pain after surgery, at a median of 118.5 (29-660) days after surgery, including in the groin, suprapubic, thigh and vaginal regions. Some of these cases, however, include patients who reported pain prior to their procedure using the EQ-5D-5L -a nonspecific quality-of-life questionnaire [14] ( Table 7) . Fourteen of these patients reported slight, moderate or severe pain prior to intervention, although the nature of this preoperative pain was not specified. Pain was reported in 3.1% of patients (6/195) 
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All the time were identified as having developed complications. The majority of these (126, 65.6%) were grade I, 44 (22.9%) were grade II and the remaining 22 (11.5%) were grade III or above. When these complications were analysed according to surgeon volume, the rate of complications was highest in the higher-volume group but this was not statistically significant (P = 0.114) and is likely to reflect the greater actual numbers of women having surgery for recurrent SUI in this group.
Although the degree of satisfaction post-surgery was only recorded for 441 patients, 375 (85%) reported being satisfied or very satisfied with the outcome of their procedure at follow-up, with 45 (10.2%) being neutral as to the outcome, and 21 (4.8%) either unsatisfied or very unsatisfied with the result (Table 9) .
Discussion
To date, this is the most comprehensive report of clinical outcomes from SUI surgery in the UK, with over 100 urological surgeons submitting data on 2917 patients, yielding a capture rate of 72% when cross-checked with HES data. Data entry remained fairly consistent across the 3 years, although follow-up data were only available in 62.8% cases. A trend for increasing input with time has previously been reported in other BAUS databases [13] , and as data submission becomes increasingly embedded into clinical practice, national database entry should continue to increase. The argument for mandating data entry, especially in view of the recent mesh controversies, is strong; however, the practicalities of funding and enforcement of mandating data entry are difficult and controversial.
It is important to note that, despite current controversy with the use of vaginal MUT for SUI, the majority of women with this condition (74.1%) underwent MUT surgery, of whom 292/327 (89.3%) were satisfied or very satisfied with the outcome of their surgery. Overall, 85% of women were satisfied or very satisfied with the outcome of their SUI surgery, and 84.5% of women reported a reduction in pad usage, with 86.3% using no or one pad per day and 55% deeming themselves dry.
There remains a significant variation in the number of procedures performed by each surgeon. Although the median number over 3 years is 20, a small group of surgeons (4.6%, 5/ 109) reported only one to two procedures a year. Whilst it has been demonstrated that surgeon volume has an impact on outcomes after radical prostatectomy [19, 20] , our data do not support this for female SUI surgery. There are few data to evaluate the outcomes of SUI surgery according to surgeon volume in the contemporary literature; however, one study evaluating factors associated with successful outcomes of SUI surgery supported our findings and stated that surgeon volume was not a significant factor [21] . The outcomes in this audit were analysed based on surgeon volume using the NICE guidance to guide the sub-groups chosen [9] and we were unable to demonstrate a significant difference in the rates of patient satisfaction and complications between these cohorts.
In this audit, only 11 of the 109 surgeons (10.1%) perform on average 20 or more procedures overall per year (the AFS, autologous fascial sling; AUS, artificial urinary sphincter; EQ-5D-5L, five-level EQ-5D quality-of-life questionnaire; TOT, transobturator tape; TVT, tension-free vaginal tape ; TVT-O, tension-free vaginal tape-obturator.
© 2018 The Authors BJU International © 2018 BJU International 155 minimum volume suggested by NICE), and no urological surgeon performs 20 of each of the recorded SUI procedures per year. Indeed the annual number of colposuspension procedures recorded in the HES database varies from 90 to 120, whilst those for female bladder neck AUS vary from 8 to 12. Given these small total numbers it is difficult to see how this particular aspect of the NICE guidance can be followed, and interrogation of the literature would suggest the recommended numbers are not evidence-based. The NICEsuggested workload of 20 cases per annum was decided by consensus among the NICE Guideline Development Group [22] , and recommended number of cases per procedure rather than overall SUI surgery caseload. This recommendation was in part supported by a survey of UK consultants performing SUI surgery; however, in that survey it was noted that 59% of urologists responding believed that an annual caseload of 10-20 SUI procedures was sufficient [23] . Although all surgeons performing SUI surgery are not captured in the database, notably urogynaecologists, the results of the present analysis would suggest that the volumeoutcome relationship does not exist for female SUI surgery.
The changing pattern of procedures performed over the 3-year period, with a reduction of MUT procedures and total number of SUI procedures, as seen in Fig. 1 , is likely to be related to change in patient preference and clinician anxiety consequent to the recent mesh controversy. This reduction in total number of SUI procedures and total number of MUT SUI procedures is mirrored in the national HES data [16] . It suggests that a significant number of women have avoided a surgical solution for SUI and continue to experience incontinence, with its significant adverse psychological, emotional and financial consequences [24] . We noted that the total number of colposuspensions has remained the same over the reported 3-year period, suggesting that surgeons remain comfortable and women appear happy to undertake this surgical treatment option. TOT was the most common procedure performed, with excellent results and low pain scores. There was very little difference in the outcomes from TOT or TVT procedures with respect to peri-operative or short-term complications. Our data are slightly at odds with the recommendations from the Scottish report [2] , which favours TVT via the retropubic approach, but are in the All cases (n = 441) 58.3% (n = 257) 26.8% (n = 118) 10.2% (n = 45) 4.1% (n = 18) 0.7% (n = 3) TOT (n = 178) 71.3% (n = 127) 20.8% (n = 37) 6.2% (n = 11) 1.1% (n = 2) 0.6% (n = 1) TVT (n = 54) 63.0% (n = 34) 29.6% (n = 16) 5.6% (n = 3) 1.9% (n = 1) 0% (n = 0) TVT-O (n = 76) 53.9% (n = 41) 28.9% (n = 22) 11.8% (n = 9) 3.9% (n = 3) 1.3% (n = 1) AFS (n = 53) 50.9% (n = 27) 28.3% (n = 15) 15.1% (n = 8) 5.7% (n = 3) 0% (n = 0) Urethral bulking agent (n = 37) 37.8% (n = 14) 27.0% (n = 10) 10.8% (n = 4) 21.6% (n = 8) 2.7% (n = 1) Colposuspension (n = 9) 33.3% (n = 3) 55.6% (n = 5) 11.1% (n = 1)
AUS, artificial urinary sphincter; TOT, transobturator tape; TVT, tension-free vaginal tape; TVT-O, tension-free vaginal tape-obturator.
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© 2018 The Authors BJU International © 2018 BJU International keeping with the recent network meta-analysis by Song et al. [25] that favours TOT. The number of bulking agents used for SUI surgery has increased over time and may reflect the belief of patients and/or clinicians that this procedure, despite being less efficacious, may be less morbid. It may be that this is the only non-'mesh' SUI surgical option in some units and patients are being offered this as a default. As mandated by NICE and recent NHS England and Scotland reviews, patients should be offered ALL suitable SUI surgical options and be referred on, as appropriate, to units that offer the patient's chosen procedure if not available locally. The BAUS Section of Female Neurological and Urodynamic Urology would support this stance and encourage use of the BAUS patient-specific patient information leaflets and the comparative SUI treatment patient information leaflet.
The rates of peri-operative complications reported are similar to those reported in other series. The overall rate of bladder perforation in this series is 1.3%, which is towards the lower end of the documented rate in other series [26, 27] . The rate of tape extrusion was low at <1%, which is well within the quoted rate in the literature [28, 29] ; however, the time to follow-up was variable, and may not represent a sufficient time period for all tape extrusions to present. A significant proportion of the patients operated on were either overweight (BMI 25-29.9 kg/m ; whether or not weight loss had occurred in our cohort of patients prior to intervention remains unknown. There is evidence to suggest that a raised BMI adversely affects success of SUI surgery [30] [31] [32] , and that in those with a BMI of > 35 kg/m 2 the cure rate is decreased after TVT insertion [31, 32] . Many patients find losing weight difficult while experiencing significant SUI as it precludes heavy physical activity. We did not find any significant association with BMI and peri-operative complications. As expected, complications were higher in those undergoing surgery for recurrent SUI (20.7% [68/328]) than in those undergoing primary surgery (8.7% [124/1 426] ). This may be related to the use of more invasive surgical options such as AFS, colposuspension and AUS, which represented 10.1% procedures performed in the primary group compared with 45.1% of recurrent SUI surgery. It should be noted that the majority of complications related to both recurrent (61/68, 89.7%) and primary (109/124, 87.9%) procedures are Clavien I and II only. In terms of resolution of urinary incontinence, lower cure rates were recorded in the recurrent group, with 72.1% of patients (220/305) reporting postoperative pad use of one pad or less per day compared with 89.4% (1 242/1 390) in the primary surgery group. In the primary surgery group 59.4% of patients (735/1237) described themselves as never leaking postoperatively, compared with 34.1% (88/258) in the recurrent surgery group. These results were possibly to be expected because of poorer quality of tissues and distorted anatomy caused by previous surgical intervention, making the nature of the surgery for recurrent SUI more complex, as well as higher preoperative pad use. Careful counselling of these patients is therefore required to ensure realistic expectations.
Conflicts of Interest
Suzanne Biers and Nikesh Thiruchelvam have received educational fees from Boston Scientific International. Chris Harding has received consultancy fees from AMS.
Almost half of the patients left theatre catheter-free, with 70% of those leaving theatre with a catheter in situ having it removed within 24 h. The reason for leaving the catheter in for > 24 h is unknown, and may be related either to operative technique, for example leaving vaginal packs in situ, the type of operation performed, or individual surgeon preference. Interpretation of the rates of unintended selfcatheterization is limited by the lack of reporting of these data; however, for those that reported, the rate of 5.5% is well within the reported range in the literature [27] and may also be influenced by the urological caseload of neurourological patients who experience SUI. There was no significant difference in the unplanned self-catheterization rates in patients with primary vs recurrent SUI. Analysis of postoperative voiding and catheterization in this series is suboptimal because of variations in data entry, which may result from lack of clarity in the database questions. This is an area that can be developed further for the purpose of future data collection.
Equally, data regarding postoperative OAB are confusing, and are probably attributable to misinterpretation of the database questions. Overall, 15.2% of those with recorded data reported de novo urgency. Previous systematic reviews have suggested de novo irritative symptoms in the range of 0-25.9% for MUT [28, 29] ; however, there is some discrepancy with the data surrounding de novo OAB as some patients report this alongside pre-existing urgency. Of those with pre-existing urgency, only 9.4% patients report a worsening of their symptoms -although the length of follow-up may not be sufficient to assess this accurately. The persistence of pre-existing OAB or new-onset OAB is one of the commonest causes of dissatisfaction with SUI surgeryand these real-life figures should be openly discussed with patients whilst we refine our methodology to determine the incidence of both more exactly in the future iterations of our database.
The patient-reported UTI rate at follow-up appointment was 7.5%. It is not, however, clear at what stage the infection happened. Only 60.3% of these had positive microscopy to confirm infection; however, it is not clear from the database if the remaining patients had negative microscopy or no microscopy sent.
Chronic severe and extreme pain occurred in 5.5% of women prior to their SUI surgery and in 5.4% after their SUI surgery, indicating that there was no significant increase in the rates of severe and extreme pain after SUI surgery above preoperative levels in the short term. The proportion reporting persistent pain at time of follow-up varies by procedure and is significantly higher for more invasive procedures; colposuspension 13.2%, AFS 6.1%, AUS 4.5%, TVT 3.1%, TOT 2.7%, TVT-O 2.6% and mini-sling 0% (P = 0.008). It is noted that MUT surgery had the lowest rates of persistent pain reported postoperatively. As the median (range) time at which postoperative pain was recorded was 100 (0-1 023) days, it is likely that a significant proportion of this pain represents resolving post-surgical pain and that a 12-month review may yield even lower levels of pain [33] . These rates are in line with other reported studies in which severe pain is reported in < 1% [33] .
We have identified weaknesses of this report and of the database; these mainly involve issues with data entry, data capture, and length of follow-up. Data are entered by the operating surgeon who has the potential for reporting bias. There are some data entry errors in the database (for example, follow-up date entered as the same date or prior to the operative date). Equally 20 women, pre-operatively, reported never leaking urine when describing the frequency of their incontinence; however, 17 of these had urodynamically confirmed urinary incontinence, and 12 reported a pad use of at least two pads per day. Secondly, time to data entry from actual patient visit (for surgery and follow-up) is variable. Furthermore the patient-related outcomes measure, which included the EQ-5D-5L, did not clearly distinguish new-onset pain which may be related to the SUI surgery from pre-existing pain. This will require review and revision for future usage. Follow-up data are incomplete and entered at a relatively short time period. Ideally, sequential data would be captured over a period of years; however, this carries significant consent and governance issues, which at present prevent this data capture on a national scale. Because of the limited follow-up period, it may well be that some of the more chronic complications, such as tape extrusion, chronic pain, OAB and lack of satisfaction are not adequately captured in this series. All of the recognized weaknesses detailed after this audit can be used to continually improve the process and hence the quality of the data obtained in the future. Participation in national audit is considered mandatory for all surgeons and should be a necessary component of the appraisal and revalidation process.
In conclusion, the present paper describes the contemporary surgical practice for female SUI in the UK by urologists, including outcomes and complications. Despite urological surgeons undertaking a low volume of procedures per year, the audit shows that female SUI surgical practice in the UK by urologists produces excellent short-term surgeon-and patient-reported outcomes and few reported peri-procedural complications. Both outcomes and complications do not appear to be related to surgeon volume but rather whether surgery is for primary or recurrent SUI, and the consequent increase in the use of more invasive procedures. Short-term chronic severe and extreme pain rates do not appear to increase postoperatively. BAUS is aware of the 'period of high vigilance restriction' in the UK regarding vaginal mesh surgery that has been recently recommended by the Cumberlege review [34] and welcome any recommendations that will help establish the nature and extent of complications experienced by women undergoing these types of surgery. Furthermore, BAUS is keen to support the implementation of processes that will ensure existing patients with complications from mesh surgery are given the opportunity to be managed in centres with the required levels of experience, expertise and resource.
